老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neoleukin Therapeutics, Inc.

3.49
0.0000
成交量：- -
成交额：39.34万
市值：3,279.87万
市盈率：-1.14
高：3.49
开：3.49
低：3.49
收：3.49
52周最高：4.70
52周最低：1.90
股本：939.79万
流通股本：544.90万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-3.0649
每股收益(LYR):-5.2115
净资产收益率：-37.88%
总资产收益率：-18.70%
市净率：0.44
市盈率(LYR):-0.67

数据加载中...

总览公司新闻资讯公告
2019/11/13

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/13

重要事件披露

Current report, items 2.02 and 9.01
2019/10/11

重要事件披露

[Amend] Current report, item 9.01
2019/10/02

重要事件披露

Current report, item 1.01
2019/08/13

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/12

持股变动声明

Initial statement of beneficial ownership of securities
2019/08/12

持股变动声明

Initial statement of beneficial ownership of securities
2019/08/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/12

重要事件披露

Current report, items 1.01, 2.01, 2.03, 3.02, 5.02, 5.03, 8.01, and 9.01
2019/08/12

持股变动声明

Initial statement of beneficial ownership of securities
2019/08/08

持股变动声明

Statement of changes in beneficial ownership of securities
2019/08/07

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/08/06

重要事件披露

Current report, items 1.01, 5.02, 7.01, and 9.01
2019/08/01

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/05/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/04/15

[修订]年度报告

[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]
2019/03/07

年度报告

Annual report [Section 13 and 15(d), not S-K Item 405]
2019/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/01/25

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
更多